Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
Address
40 GUEST STREET
BOSTON, MA 02135
Founded
2014
Number of Employees
53
Website
http://www.cuebiopharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)